427 related articles for article (PubMed ID: 23840897)
61. [Function and mechanism of tumor suppressor gene FBW7 in tumorigenesis].
Huang HJ; Zheng F; Xu FP; Liu YH; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):214-6. PubMed ID: 23769449
[No Abstract] [Full Text] [Related]
62. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
[TBL] [Abstract][Full Text] [Related]
63. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
64. Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts.
Masuda K; Ishikawa Y; Onoyama I; Unno M; de Alborán IM; Nakayama KI; Nakayama K
Oncogene; 2010 Mar; 29(12):1798-809. PubMed ID: 20023701
[TBL] [Abstract][Full Text] [Related]
65. Repression of YEATS2 induces cellular senescence in hepatocellular carcinoma and inhibits tumor growth.
Wu Q; Zheng Q; Yuan L; Gao D; Hu Y; Jiang X; Zhai Q; Liu M; Xu L; Xu H; Ye J; Zhang F
Cell Cycle; 2024 Feb; 23(4):478-494. PubMed ID: 38619971
[TBL] [Abstract][Full Text] [Related]
66. MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma.
El-Mezayen H; Yamamura K; Yusa T; Nakao Y; Uemura N; Kitamura F; Itoyama R; Yamao T; Higashi T; Hayashi H; Imai K; Chikamoto A; Yamashita YI; Baba H
Ann Surg Oncol; 2021 Nov; 28(12):7973-7982. PubMed ID: 33886022
[TBL] [Abstract][Full Text] [Related]
67. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.
Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S
Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148
[TBL] [Abstract][Full Text] [Related]
68. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
69. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.
Onoyama I; Suzuki A; Matsumoto A; Tomita K; Katagiri H; Oike Y; Nakayama K; Nakayama KI
J Clin Invest; 2011 Jan; 121(1):342-54. PubMed ID: 21123947
[TBL] [Abstract][Full Text] [Related]
70. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
Zhang JF
Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
[TBL] [Abstract][Full Text] [Related]
72. hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53.
Kimura T; Gotoh M; Nakamura Y; Arakawa H
Cancer Sci; 2003 May; 94(5):431-6. PubMed ID: 12824889
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
74. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.
Kuhn E; Wu RC; Guan B; Wu G; Zhang J; Wang Y; Song L; Yuan X; Wei L; Roden RB; Kuo KT; Nakayama K; Clarke B; Shaw P; Olvera N; Kurman RJ; Levine DA; Wang TL; Shih IeM
J Natl Cancer Inst; 2012 Oct; 104(19):1503-13. PubMed ID: 22923510
[TBL] [Abstract][Full Text] [Related]
75. Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells.
Yeh CH; Bellon M; Wang F; Zhang H; Fu L; Nicot C
Mol Cancer; 2020 Sep; 19(1):139. PubMed ID: 32907612
[TBL] [Abstract][Full Text] [Related]
76. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.
Mao JH; Kim IJ; Wu D; Climent J; Kang HC; DelRosario R; Balmain A
Science; 2008 Sep; 321(5895):1499-502. PubMed ID: 18787170
[TBL] [Abstract][Full Text] [Related]
77. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
[TBL] [Abstract][Full Text] [Related]
78. An integrated view of cyclin E function and regulation.
Siu KT; Rosner MR; Minella AC
Cell Cycle; 2012 Jan; 11(1):57-64. PubMed ID: 22186781
[TBL] [Abstract][Full Text] [Related]
79. Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma.
Koom WS; Park SY; Kim W; Kim M; Kim JS; Kim H; Choi IK; Yun CO; Seong J
J Radiat Res; 2012; 53(2):202-10. PubMed ID: 22510592
[TBL] [Abstract][Full Text] [Related]
80. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
